AST SpaceMobile Inc vs Summit Therapeutics Inc — how do they compare? AST SpaceMobile Inc trades at $71.61 (market cap $20.54B), while Summit Therapeutics Inc trades at $15.6 (market cap $12.06B). The key difference: AST SpaceMobile Inc is the larger of the two by market cap, and AST SpaceMobile Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ASTS | SMMT | |
|---|---|---|
Market Cap | $20.54B | $12.06B |
Sector | Media | Health |
52-Week High | $133.09 | $26.98 |
52-Week Low | $36.91 | $12.55 |
Enterprise Value | $21.25B | $11.39B |
Trailing returns across standard periods
Latest headlines on both assets
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →